Cabaletta Bio, Inc. (CABA)
NASDAQ: CABA · Real-Time Price · USD
2.860
-0.050 (-1.72%)
At close: Apr 28, 2026, 4:00 PM EDT
2.850
-0.010 (-0.35%)
Pre-market: Apr 29, 2026, 8:53 AM EDT
Cabaletta Bio Market Cap
Cabaletta Bio has a market cap or net worth of $318.38 million as of April 29, 2026. Its market cap has increased by 410.11% in one year.
Market Cap
318.38M
Enterprise Value
211.88M
1-Year Change
410.11%
Ranking
Category
Stock Price
$2.86
Market Cap Chart
Since October 25, 2019, Cabaletta Bio's market cap has increased from $235.53M to $318.38M, an increase of 35.18%. That is a compound annual growth rate of 4.74%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Palisade Bio | 348.24M |
| Ovid Therapeutics | 342.87M |
| DiaMedica Therapeutics | 341.08M |
| Bicycle Therapeutics | 337.38M |
| Greenwich LifeSciences | 335.42M |
| Nautilus Biotechnology | 331.60M |
| Surrozen | 323.24M |
| Rezolute | 322.00M |